Manual de condutas em oncologia (2013)
- Autores:
- Autores USP: HOFF, PAULO MARCELO GEHM - FM ; PEREIRA, JULIANA - FM
- Unidade: FM
- Assuntos: NEOPLASIAS; ONCOLOGIA; CONDUTAS TERAPÊUTICAS; MANUAIS
- Idioma: Português
- Imprenta:
- Editora: Editora Atheneu
- Local: São Paulo
- Data de publicação: 2013
- Descrição física: 362 p
-
ABNT
HOFF, Paulo Marcelo Gehm et al. Manual de condutas em oncologia. . São Paulo: Editora Atheneu. . Acesso em: 07 out. 2024. , 2013 -
APA
Hoff, P. M. G., Diz, M. D. P. E., Pereira, J., Testa, L., & Mak, M. P. (2013). Manual de condutas em oncologia. São Paulo: Editora Atheneu. -
NLM
Hoff PMG, Diz MDPE, Pereira J, Testa L, Mak MP. Manual de condutas em oncologia. 2013 ;[citado 2024 out. 07 ] -
Vancouver
Hoff PMG, Diz MDPE, Pereira J, Testa L, Mak MP. Manual de condutas em oncologia. 2013 ;[citado 2024 out. 07 ] - CD4+ lymphocytes in asymptomatic HTLV-1 carriers present cell cycle arrest in GO/G1 phase
- Expression of CysLTR1 and 2 in Maturating Lymphocytes of Hyperplasic Tonsils Compared to Peripheral Cells in Children
- Macrophage migration inhibitory factor and chemokine RANTES in young pediatric patients with congenital cardiac communications: relation to hemodynamic parameters and the presence of Down syndrome
- Câncer e Doenças Cardiovasculares na Pandemia de COVID-19
- Time-to-treatment of diffuse large B-cell lymphoma in São Paulo
- Bortezomib (Btz) dose intensity is the strongest predictor for overall survival (OS) in mantle cell lymphoma (MCL) patients (Pts) not considered for transplantation, receiving frontline Btz plus rituximab, cyclosphosphamide, doxorubicin, and prednisone (VR-CAP) therapy in the phase 3 LYM 3002 study
- Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances
- Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma
- Comparison between R-CHOP vs R-CHOP plus etoposide in untreated patients with primary mediastinal B-cell lymphoma: Preliminary findings
- 18 F-FDG pet interim and determination of cellular origin by immunohistochemistry identify a group of very good prognosis in patients with diffuse large B cell lymphoma in the rituximab era
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas